Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 2341–2360 of 17,529 recalls

March 13, 2023· Direct Rx

Recalled Item: Simvastatin

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 13, 2023· Direct Rx

Recalled Item: Ropinirole

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 13, 2023· Direct Rx

Recalled Item: Glimepiride

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 13, 2023· Direct Rx

Recalled Item: Glimepiride

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 13, 2023· Direct Rx

Recalled Item: Ropinirole

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 13, 2023· Direct Rx

Recalled Item: Simvastatin

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 13, 2023· Direct Rx

Recalled Item: Finasteride

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 13, 2023· Direct Rx

Recalled Item: Montelukast Sodium Tablets

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 13, 2023· Direct Rx

Recalled Item: Simvastatin

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII

The Issue: Defective Delivery System: Out of specification for shear

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII

The Issue: Defective Delivery System: Out of specification for shear

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII

The Issue: Defective Delivery System: Out of specification for shear

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII

The Issue: Defective Delivery System: Out of specification for shear

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 9, 2023· Boehringer Ingelheim Pharmaceuticals, Inc.

Recalled Item: JARDIANCE (Empagliflozin)

The Issue: Labeling: Label Mix-up

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 9, 2023· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Dofetilide Capsules

The Issue: Failed Content Uniformity Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 8, 2023· Pfizer Inc.

Recalled Item: MEKTOVI (binimetinib) tablets

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
March 2, 2023· Endo Pharmaceuticals, Inc.

Recalled Item: Calcitonin Salmon Nasal Spray

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 2, 2023· Breckenridge Pharmaceutical, Inc

Recalled Item: Alprazolam Tablets

The Issue: CGMP Deviations: Potential risk of Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 2, 2023· Breckenridge Pharmaceutical, Inc

Recalled Item: Alprazolam Tablets

The Issue: CGMP Deviations: Potential risk of Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 2, 2023· Breckenridge Pharmaceutical, Inc

Recalled Item: Alprazolam Tablets

The Issue: CGMP Deviations: Potential risk of Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund